Why are Medicare and Medicaid shown separately instead of combined?

They come from two different CMS data sources with no shared claim identifier, so they can't be reconciled into one number without double-counting or guessing. Every table and chart on this page keeps them fully separate.

Why is there no private/commercial revenue figure?

Private and commercial payer data comes from Transparency in Coverage files, which only publish negotiated rates — not claims or utilization volume. Without a volume figure, no revenue number can be computed for any provider from that data.

What does "Rank" mean in the Competitive Analysis & Benchmarks tables?

For a given CPT/HCPCS code, it's this provider's position by claims volume among all providers billing that same code at that geography level (State, National, or Louisiana for Medicaid) — rank 1 means the highest claims volume for that code.

Why is the Medicaid comparison limited to Louisiana only?

Medicaid is administered per-state with no single national fee schedule, so a state or national comparison the way Medicare has one isn't available. Louisiana (this provider's own state) is the only grouping that's conceptually meaningful.

Why are the numbers rounded to the nearest 10?

To avoid implying more precision than the underlying data supports at a single-provider level. Ratios are kept precise since they're a relative comparison, not a volume or dollar figure.

How current is this data?

The Medicare and Medicaid tables are both single current snapshots, not refreshed on a recurring schedule yet.

Kirtan Koticha (NPI 1528279965)

Field	Value
Entity Type	Individual
Organization	Kirtan Koticha
Address	1455 E Bert Koun Loop # 101
City	Shreveport
State	LA
ZIP	71105
Taxonomy	Hematology & Oncology Physician
NPI Enumerated	May 25, 2007

Payer Source	Total Paid
Medicare	$3.1M
Medicaid	$0

Key Findings

KIRTAN KOTICHA has an established Medicare billing footprint with Total Medicare revenue of $3.1M and no Medicaid billing on file, making this provider effectively single‑payer (Medicare) for public payers. The NPI was enumerated 2007-05-25 (~19 years ago), indicating long tenure and likely sustained practice presence in the Shreveport market.

Revenue is highly concentrated in a few drug and E/M codes: the precomputed top 3 Medicare codes by revenue account for 71.6% of this provider's total Medicare revenue, driven principally by J9271 (51.5%), J0897 (14.3%), and 99215 (5.8%). This concentration means most Medicare dollars are coming from a narrow set of high-cost oncology injections and complex office visits.

The code mix and volumes indicate an infusion-centered oncology practice: J9271 (pembrolizumab) shows 35.8K claims and $1.5M revenue, and J0897 (denosumab) shows 23.7K claims and $426.6K revenue, while chemotherapy administration code 96413 appears with 1.1K claims and $103.9K revenue. Together with high-count supportive and administration codes, the data point to routine in-office infusions, systemic anti-cancer therapy, and associated supportive care.

Competitive standing for key oncology products is strong nationally: J9271 ranks #54 of 1841 providers nationally (97th percentile; notably above typical national volume), J0897 ranks #186 of 10057 providers nationally (98th percentile; extreme outlier), and 99215 ranks #102 of 145531 providers nationally (100th percentile; extreme outlier). These ranks indicate the provider is a major national outlier on volume for these specific oncology and E/M services rather than a modest participant.

Operational intensity is supported by high volumes of ancillary and infusion-related services: Q5122 (pegfilgrastim-apgf) has 1.7K claims and $156.6K revenue and ranks #6 of 239 providers (98th percentile; notably above typical national volume), 96372 shows 1.3K claims and ranks #228 of 58224 providers (100th percentile; extreme outlier), and 96413 ranks #47 of 7514 providers (99th percentile; extreme outlier). In-office lab and phlebotomy usage is also elevated (80053: 3.2K claims, 36415: 3.9K claims), suggesting integrated diagnostic support for chemotherapy patients.

The provider demonstrates notable adoption of biosimilars and a mixed biologic drug portfolio: Q5122 (pegfilgrastim biosimilar) ranks #6 of 239 (98th percentile), and Q5104 (infliximab-abda biosimilar) appears with 2.6K claims and $78K revenue. High ranks for biosimilar pegfilgrastim combined with heavy pembrolizumab and denosumab use suggest a practice balancing expensive immune/targeted therapies with biosimilar supportive agents.

For payers and contracting analysts, the concentration of Medicare revenue in a small set of high-cost injectable oncology drugs—particularly J9271 at $1.5M revenue and J0897 at $426.6K—signals that reimbursement negotiations, utilization management, or network decisions should focus on infusion drug use and administration workflows. The absence of Medicaid billing on file limits visibility into state program exposure and suggests minimal direct Medicaid financial risk from this provider.

Medicare: Complete Services Breakdown

The CPT/HCPCS codes generating the most Medicare revenue for this provider.

70 rows

CPT/HCPCS Code	Description	Claims	Avg Paid	Revenue
J9271	Injection, pembrolizumab, 1 mg	35,800	$40	$1.5M
J0897	Injection, denosumab, 1 mg	23,700	$20	$426.6K
99215	The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a high level of medical decision making, and/or the…	1,310	$130	$172.7K
Q5122	Injection, pegfilgrastim-apgf (nyvepria), biosimilar, 0.5 mg	1,740	$90	$156.6K
J1437	Injection, ferric derisomaltose, 10 mg	6,600	$20	$105.6K
96413	Chemotherapy is a therapeutic procedure used for the treatment of cancer via the use of chemical agents. These chemical agents (drugs) work on the cancerous cells of the body to destroy them. These…	1,130	$90	$103.9K
Q5104	Injection, infliximab-abda, biosimilar, (renflexis), 10 mg	2,600	$30	$78K
99214	The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the…	790	$90	$73.5K
J0885	Injection, epoetin alfa, (for non-esrd use), 1000 units	11,320	$10	$67.9K
80053	The lab analyst performs a comprehensive metabolic panel, or CMP test in which he measures the blood level of 14 chemicals the code descriptor lists for the panel.	3,200	$10	$32K

Showing 1–10 of 70

Medicare: Competitive Analysis & Benchmarks

How this provider's Medicare billing volume and revenue compare to other providers nationally and within its state, across 70 CPT/HCPCS codes.

View: State1 / 2

Claims Volume vs. Louisiana Distribution

Kirtan Koticha — 17 of 25 codes billed far more than typical (above p95)

p5–p95 (all providers)p25–p75MedianThis providerOutlier

Rank Distribution — Louisiana

Full comparison — all codes billed, vs. state median

70 rows

CPT/HCPCS Code	Rank	Provider Count	Median Claims	Avg Paid	Average Revenue
J9271	1	10	13,800	$40	$635.1K
Q5122	1	10	1,740	$90	$157.2K
J0897	3	70	3,120	$20	$105.6K
Q5104	2	10	2,600	$30	$95.4K
J1745	8	10	3,110	$30	$80K
J3490	5	20	50	$620	$49.1K
96521	9	10	330	$80	$44.6K
J1437	1	10	1,900	$20	$41.9K
J0885	1	10	6,670	$10	$39K
96413	3	70	140	$90	$22.8K

Showing 1–10 of 70

Related Providers

Other providers that share a Tax Identification Number (TIN) with Kirtan Koticha, ranked by combined Medicare and Medicaid revenue.

Provider	State	Taxonomy	Medicare Revenue	Medicaid Revenue
Ryan Olson	FL	Anatomic Pathology & Clinical Pathology Physician	$12.8M	$80
Highland Clinic, A Prof Med Corp	LA	Multi-Specialty Clinic/Center	$0	$5.9M
James Keane	AR	Procedural Dermatology Physician	$4.9M	$0
Harshivinderjit Bains	TX	Ophthalmology Physician	$4.1M	$0
Balagopalan Nair	AR	Hematology & Oncology Physician	$4.1M	$0
Shanda Jackson	LA	Family Nurse Practitioner	$4M	$0
Amar Patel	TX	Ophthalmology Physician	$3.8M	$0
Thomas Bochow	TX	Ophthalmology Physician	$3.6M	$0
James Russo	LA	Radiation Oncology Physician	$3.5M	$0
Richard Kinsey	TN	Anatomic Pathology & Clinical Pathology Physician	$3.3M	$147.3K

Nearby Providers

Other providers in the same ZIP code as Kirtan Koticha, ranked by combined Medicare and Medicaid revenue.

Provider	State	Taxonomy	Medicare Revenue	Medicaid Revenue
Wk Urgent Care Center-pierremont	LA	Family Medicine Physician	$0	$25M
Sincere Client Care Service	LA	Home Health Agency	$0	$13.4M
Christus Health Northern Louisiana	LA	General Acute Care Hospital	$0	$12.6M
Afnb Home Care LLC	LA	In Home Supportive Care Agency	$0	$11.2M
Sincere Client Care Service	LA	Home Health Agency	$0	$9.9M
Caring Hands Pediatric Day Health Center, LLC	LA	Medically Fragile Infants and Children Day Care	$0	$7.5M
Ocean Dental Of Louisiana, P.C.	LA	General Practice Dentistry	$0	$6.6M
Autumn Creek Health Solutions Inc	LA	Mental Health Clinic/Center (Including Community Mental Health Center)	$0	$4.9M
Russell Fileccia	LA	Cardiovascular Disease Physician	$2.6M	$0
Northern Louisiana Cardiac Services LLC	LA	Ambulatory Surgical Clinic/Center	$2.4M	$0

Kirtan Koticha — Billing Profile & Reimbursement Data

Sign up for Kirtan Koticha — Billing Profile & Reimbursement Data policy alerts

Kirtan Koticha — Billing Profile & Reimbursement Data

Sign up for Kirtan Koticha — Billing Profile & Reimbursement Data policy alerts

Key Findings

Medicare: Total Revenue Breakdown by CPT/HCPCS Code

Medicare: Complete Services Breakdown

Medicare: Competitive Analysis & Benchmarks

Related Providers

Nearby Providers

Frequently Asked Questions

References